Joinn Laboratories(China)Co.,Ltd. (HKG:6127)

Market Cap	29.55B +72.9%
Revenue (ttm)	1.84B -17.9%
Net Income	331.44M +302.1%
EPS	0.45 +300.0%
Shares Out	n/a
PE Ratio	89.15
Forward PE	829.82
Dividend	0.00 (0.01%)
Ex-Dividend Date	Jun 26, 2025

Volume	2,528,250
Average Volume	5,912,154
Open	21.88
Previous Close	21.98
Day's Range	21.88 - 23.10
52-Week Range	9.36 - 28.70
Beta	0.92
RSI	61.35
Earnings Date	Mar 30, 2026

About HKG:6127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. Its Clinical Trial and Related Services segment provide clinical contract research organization s...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1995
• Employees: 2,652
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6127

Financial Performance

In 2025, HKG:6127's revenue was 1.66 billion, a decrease of -17.87% compared to the previous year's 2.02 billion. Earnings were 297.84 million, an increase of 302.08%.

Financial numbers in CNY